Iron-utilizing proteins

Iron-utilizing proteins represent a broad functional class of molecules that incorporate iron as a critical cofactor to perform essential biological processes, including oxygen transport (e.g., hemoglobin), electron transfer (e.g., cytochromes), and DNA synthesis (e.g., ribonucleotide reductase) [StatPearls: Iron Deficiency Anemia]. These proteins are vital for cellular metabolism and energy production, but their dysregulation is linked to various pathologies; for instance, cancer cells often exhibit an increased iron demand to support rapid proliferation via upregulated iron-utilizing enzymes [PubMed: PMC6429132]. In the context of infectious diseases, many pathogens utilize specialized iron-acquisition proteins to scavenge iron from the host, making these systems attractive targets for antimicrobial therapy [Nature Reviews Microbiology: 10.1038/nrmicro.2017.100]. Therapeutic interventions targeting this group include iron chelators like deferoxamine, which deplete the available iron pool, and specific inhibitors of iron-dependent enzymes [PubChem: Deferoxamine]. However, because iron is a fundamental requirement for almost all living cells, therapeutic strategies must carefully balance efficacy against the risk of systemic iron deficiency or off-target effects on host metalloproteins [NIH: Iron Fact Sheet for Health Professionals].

Other names

Iron-binding proteinsMetalloproteins (iron-containing)HemoproteinsIron-sulfur cluster proteinsNon-heme iron enzymes

Iron chelation to reduce bioavailability, iron supplementation to restore levels, or inhibition of specific iron-dependent enzymes like ribonucleotide reductase.